The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer

被引：0
|
作者：
Ching-Wen Huang
Hsiang-Lin Tsai
Yi-Ting Chen
Chun-Ming Huang
Cheng-Jen Ma
Chien-Yu Lu
Chao-Hung Kuo
Deng-Chyang Wu
Chee-Yin Chai
Jaw-Yuan Wang
机构：
[1] Kaohsiung Medical University,Graduate Institute of Medicine, College of Medicine
[2] Kaohsiung Medical University,Department of Surgery, Kaohsiung Municipal Hsiao
[3] Kaohsiung Medical University Hospital,Kang Hospital
[4] Kaohsiung Medical University,Division of Gastrointestinal and General Surgery, Department of Surgery
[5] Kaohsiung Medical University,Cancer Center, Kaohsiung Medical University Hospital
[6] Kaohsiung Medical University Hospital,Division of General Surgery Medicine, Department of Surgery
[7] Fooyin University,Program of Bachelor of Health Beauty, School of Medical and Health Sciences
[8] Kaohsiung Medical University,Department of Pathology, Kaohsiung Medical University Hospital
[9] Kaohsiung Medical University Hospital,Department of Radiation Oncology
[10] Kaohsiung Medical University,Graduate Institute of Clinical Medicine, College of Medicine
[11] Kaohsiung Medical University Hospital,Division of Gastroenterology, Department of Internal Medicine
[12] Kaohsiung Medical University,Department of Internal Medicine, Faculty of Medicine, College of Medicine
[13] Kaohsiung Medical University,Department of Pathology, Faculty of Medicine, College of Medicine
[14] Kaohsiung Medical University,Department of Surgery, Faculty of Medicine, College of Medicine
[15] Kaohsiung Medical University,undefined
来源：
BMC Cancer | / 13卷
关键词：
Epidermal growth factor receptor; Prognostic value; Metachronous; Synchronous; Metastatic colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Synchronous and metachronous liver metastases in patients with colorectal cancer
    Okholm, Cecilie
    Mollerup, Talie Khadem
    Schultz, Nicolai Aagaard
    Strandby, Rune Broni
    Achiam, Michael Patrick
    [J]. DANISH MEDICAL JOURNAL, 2018, 65 (12):
  • [42] KRAS and EGFR MicroRNAs Regulation and Cetuximab/Panitumumab Sensitivity in Metastatic Colorectal Cancer Patients
    Landi, L.
    Biagioni, F.
    Ludovini, V.
    Sacconi, A.
    D'Arcangelo, M.
    Destro, A.
    Blandino, G.
    Roncalli, M.
    Crino, L.
    Cappuzzo, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S417 - S417
  • [43] Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients
    Yuan, Ye
    Liu, Yingting
    Wu, Ye
    Zhang, Junling
    Shen, Chunti
    Zhang, Feng
    Wu, Changping
    Hu, Wenwei
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2021, 36 (02): : 33 - 39
  • [44] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Daeyoun David Won
    Jae Im Lee
    In Kyu Lee
    Seong-Taek Oh
    Eun Sun Jung
    Sung Hak Lee
    [J]. BMC Cancer, 17
  • [45] EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab
    Razis, Evangelia
    Pentheroudakis, George
    Rigakos, George
    Bobos, Mattheos
    Kouvatseas, George
    Tzaida, Olympia
    Makatsoris, Thomas
    Papakostas, Pavlos
    Bai, Maria
    Goussia, Anna
    Samantas, Epaminontas
    Papamichael, Demetrios
    Romanidou, Ourania
    Efstratiou, Ioannis
    Tsolaki, Eleftheria
    Psyrri, Amanda
    De Roock, Wendy
    Bafaloukos, Dimitrios
    Klouvas, George
    Tejpar, Sabine
    Kalogeras, Konstantine T.
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 737 - 748
  • [46] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Won, Daeyoun David
    Lee, Jae Im
    Lee, In Kyu
    Oh, Seong-Taek
    Jung, Eun Sun
    Lee, Sung Hak
    [J]. BMC CANCER, 2017, 17
  • [47] EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer
    Khan, Sajid A.
    Zeng, Zhaoshi
    Shia, Jinru
    Paty, Philip B.
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (03) : 673 - 677
  • [48] Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
    Di Fiore, F.
    Charbonnier, F.
    Lefebure, B.
    Laurent, M.
    Le Pessot, F.
    Michel, P.
    Frebourg, T.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 551 - 552
  • [49] Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
    F Di Fiore
    F Charbonnier
    B Lefebure
    M Laurent
    F Le Pessot
    P Michel
    T Frebourg
    [J]. British Journal of Cancer, 2008, 99 : 551 - 552
  • [50] Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
    Kishiki, Tomokazu
    Ohnishi, Hiroaki
    Masaki, Tadahiko
    Ohtsuka, Kouki
    Ohkura, Yasuo
    Furuse, Jyunji
    Sugiyama, Masanori
    Watanabe, Takashi
    [J]. ONCOLOGY REPORTS, 2014, 32 (01) : 57 - 64
12345